ApoE Suppresses Atherosclerosis by Reducing Lipid Accumulation in Circulating Monocytes and the Expression of Inflammatory Molecules on Monocytes and Vascular Endothelium
Author(s) -
Nathalie Gaudreault,
Nikit Kumar,
Jessica M. Posada,
Kyle Stephens,
Nabora Soledad Reyes de Mochel,
Delphine Eberlé,
Victor Olivas,
Roy Kim,
Matthew Harms,
Sean Johnson,
Louis M. Messina,
Joseph H. Rapp,
Robert L. Raffaı̈
Publication year - 2011
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.111.238964
Subject(s) - apolipoprotein e , apolipoprotein b , ldl receptor , endocrinology , medicine , hyperlipidemia , lipoprotein , cholesterol , monocyte , proinflammatory cytokine , inflammation , endothelium , biology , chemistry , diabetes mellitus , disease
We investigated atheroprotective properties of apolipoprotein (apo) E beyond its ability to lower plasma cholesterol. We hypothesized that apoE reduces atherosclerosis by decreasing lipid accumulation in circulating monocytes and the inflammatory state of monocytes and the vascular endothelium.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom